Showing results (1971-1980 of 5,493) with videos related to

Sort By:
Pageof 550
Pharmacotherapy|March 20, 2014
Economic evaluations of clinical pharmacy services: 2006-2010Daniel R Touchette, Fred Doloresco, Katie J Suda, et al.
Pharmacotherapy|March 20, 2014
Evaluation of dabigatran bleeding adverse reaction reports in the FDA adverse event reporting system during the first year of approvalKevin W McConeghy, Adam Bress, Dima M Qato, et al.
Pharmacotherapy|March 20, 2014
Successful use of fondaparinux early after mechanical aortic valve replacement in a patient with a history of heparin-induced thrombocytopeniaKatie L Willenborg
Pharmacotherapy|March 13, 2014
Prophylactic use of pegfilgrastim in patients treated with a nitrosourea and teniposide for recurrent gliomaAnna-Luisa Thiepold, Sophie Lemercier, Kea Franz, et al.
Pharmacotherapy|March 4, 2021
Extracorporeal treatments for isoniazid poisoning: Systematic review and recommendations from the EXTRIP workgroupJames B Mowry, Greene Shepherd, Robert S Hoffman, et al.
Pharmacotherapy|March 3, 2021
Lack of drug interaction between levetiracetam and high-dose methotrexate in patients with lymphomaCatherine E DeFino, Jason N Barreto, Amanda G Pawlenty, et al.
Pharmacotherapy|July 24, 2019
Association between Use of Methadone, Other Central Nervous System Depressants, and QTc Interval-Prolonging Medications and Risk of Mortality in a Large Cohort of Women Living with or at Risk for Human Immunodeficiency Virus InfectionBani Tamraz, Lori Reisner, Audrey L French, et al.
Pharmacotherapy|January 1, 1985
The effect of ranitidine and cimetidine on single-dose diltiazem pharmacokineticsL C Winship, J M McKenney, J T Wright, et al.
Pharmacotherapy|January 1, 1985
Problems in designing hemodialysis drug studiesT P Gibson
Pharmacotherapy|October 22, 2022
Effects of GLP-1 receptor agonists on cardiovascular outcomes in patients with type 2 diabetes and chronic kidney disease: A systematic review and meta-analysisMichael Kelly, Jelena Lewis, Hindu Rao, et al.
Pageof 550